FDA Grants Full Approval of a Drug to Control Seizures in Dogs with Idiopathic Epilepsy

The U.S. Food and Drug Administration has granted full approval to KBroVet (potassium bromide chewable tablets) for the control of seizures in dogs with idiopathic epilepsy, a type of seizure disorder without a known cause.

KBroVet is orally administered daily for the control of seizures associated with idiopathic epilepsy in dogs. It is available only by prescription due to the professional veterinary expertise required to diagnose idiopathic epilepsy and to monitor safe use of the product, including treatment of any adverse reactions.

It is important for owners of dogs with idiopathic epilepsy to work closely with their veterinarians to monitor clinical signs to help avoid bromide intoxication, which occurs when high levels of bromide overwhelm the nervous system. It is also important to avoid abrupt diet changes in dogs receiving potassium bromide because it could either compromise seizure control or raise safety concerns. Signs of severe bromide intoxication can include depression, behavioral changes, poor coordination, weakness or partial loss of voluntary movement in hind limbs, dilated pupils, stupor and coma.